At Galderma, we've been dedicated to skin health for over 40 years. Founded in 1981, we're the only truly scaled pure-play dermatology company, working exclusively with the human body's largest organ. Our 7,000+ employees across approximately 90 countries deliver science-based solutions across Injectable Aesthetics, Dermatological Skincare, and Therapeutic Dermatology. We achieved 4.410 billion USD in net sales in 2024, reflecting our leadership position in the dermatology market.
We believe everyone's skin story is unique. That's why we've built a portfolio of premium brands that meet diverse individual needs. From our roots as a joint venture between Nestlé and L'Oréal, to becoming the world's largest independent global dermatology company in 2019, and our IPO on the SIX Swiss Exchange in 2024, we've remained focused on advancing dermatology through innovation, scientific rigor, and partnership with healthcare professionals. Our unique Integrated Dermatology Strategy drives our growth as we continue developing breakthrough treatments and training programs through our Global Aesthetic Injector Network.